DCM
HAE icon

Driehaus Capital Management’s Haemonetics HAE Stock Holding History

Driehaus Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,760
Closed -$600K – 525
2019
Q3 		$600K Buy
+4,760
New +$604K 0.02% 392
2019
Q1 		– Sell
-19,246
Closed -$1.93M – 441
2018
Q4 		$1.93M Buy
+19,246
New +$2.02M 0.08% 228

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Driehaus Capital Management's HAE Position: Q4 2019 in Review

Driehaus Capital Management sold out of Haemonetics (HAE) in Q4 2019, closing a stake of 4,760 shares — an estimated $600K sold.

Driehaus Capital Management first reported a position in HAE in Q4 2018 and held it in 2 quarters. The position peaked at $1.93M in Q4 2018. 298 funds tracked by Wall St. Rank hold HAE as of Q4 2019.

  • Driehaus Capital Management reported no remaining Haemonetics position as of Q4 2019 after selling out during the quarter.
  • Driehaus Capital Management sold 4,760 Haemonetics shares in Q4 2019, an estimated $600K.
  • Driehaus Capital Management first reported a position in Haemonetics in Q4 2018 and held it in 2 quarters.
  • Driehaus Capital Management's Haemonetics position peaked at $1.93M in Q4 2018.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q4 2019.

Based on Driehaus Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.